Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Profire Energy | PFIE | Apr 26, 2024 | 1.79 | -0.56 |
Profound Medical | PROF | Apr 26, 2024 | 8.03 | 0.00 |
ProFrac A | ACDC | Apr 26, 2024 | 8.23 | +1.60 |
PROG | PRG | Apr 26, 2024 | 34.02 | -2.58 |
Progress Software | PRGS | Apr 26, 2024 | 50.34 | -0.71 |
Progressive | PGR | Apr 26, 2024 | 208.03 | -0.97 |
Progyny | PGNY | Apr 26, 2024 | 32.04 | -1.42 |
Project Energy Reimagined Acquisition A | PEGR | Apr 26, 2024 | 8.89 | -3.05 |
Project Energy Reimagined Acquisition Unit | PEGRU | Apr 26, 2024 | 8.45 | 0.00 |
ProKidney | PROK | Apr 26, 2024 | 2.12 | -21.77 |
Prologis | PLD | Apr 26, 2024 | 104.06 | +0.69 |
ProMIS Neurosciences | PMN | Apr 26, 2024 | 1.98 | +1.54 |
PropertyGuru | PGRU | Apr 26, 2024 | 3.75 | +2.74 |
ProPetro | PUMP | Apr 26, 2024 | 8.98 | +2.75 |
ProPhase Labs | PRPH | Apr 26, 2024 | 4.71 | -4.85 |
ProQR Therapeutics | PRQR | Apr 26, 2024 | 1.94 | -1.02 |
PROS | PRO | Apr 26, 2024 | 33.98 | +0.15 |
Proshares Ultra FTSE Europe | UPV | Apr 26, 2024 | 60.95 | +1.56 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | Apr 26, 2024 | 73.65 | +3.41 |
Proshares Ultrashort FTSE Europe | EPV | Apr 26, 2024 | 8.05 | -1.41 |
ProSomnus | OSA | Apr 26, 2024 | 0.47 | 0.00 |
Prospect Capital | PSEC | Apr 26, 2024 | 5.27 | +0.57 |
Prospect Capital A Pref | PSEC-A | Apr 26, 2024 | 17.52 | +1.48 |
Prosperity Bancshares | PB | Apr 26, 2024 | 63.55 | -0.90 |
Protagonist Therapeutics | PTGX | Apr 26, 2024 | 25.15 | +1.99 |
Protalix Bio Therapeutics | PLX | Apr 26, 2024 | 1.15 | -2.54 |
Protara Therapeutics | TARA | Apr 26, 2024 | 2.92 | -4.10 |
Prothena | PRTA | Apr 26, 2024 | 20.87 | +1.51 |
Proto Labs | PRLB | Apr 26, 2024 | 31.37 | -0.16 |
Provident Bancorp | PVBC | Apr 26, 2024 | 8.88 | -4.93 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.